GeoVax's New Vaccine Development Aims to Address Critical U.S. Biosecurity Gap
GeoVax's development of a domestic Mpox and smallpox vaccine represents a significant step toward reducing U.S. dependence on foreign vaccine manufacturers, addressing a major national security vulnerability exposed during the 2022 Mpox outbreak.
